Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

(R) -Benzyl 2-cyclopropyl-2-hydroxyacetate

(R) -Benzyl 2-cyclopropyl-2-hydroxyacetate can be used in the synthesis of pyrrolidines, a relevant molecule for ADC applications[1].

Product Specifications

CAS Number

[2414393-47-6]

UNSPSC

12352203

Hazard Statement

H302, H315, H319, H335

Target

ADC Payload

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/r-benzyl-2-cyclopropyl-2-hydroxyacetate.html

Purity

99.08

Solubility

DMSO : 200 mg/mL (ultrasonic)

Smiles

O=C(OCC1=CC=CC=C1)[C@@H](C2CC2)O

Molecular Formula

C12H14O3

Molecular Weight

206.24

Precautions

H302, H315, H319, H335

References & Citations

[1]Kajita, et al. Production method for pyrrolidine compounds. World Intellectual Property Organization, WO2021166934 A1. 2021-08-26.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

ADC Related

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Tissue FFPE Sections, Rectum
CS716762 5x 5 µm

Tissue FFPE Sections, Rectum

Ask
View Details
ATAD3A (NM_001170535) Human Tagged ORF Clone Lentiviral Particle
RC230314L4V 200 µL

ATAD3A (NM_001170535) Human Tagged ORF Clone Lentiviral Particle

Ask
View Details
FEZ2 Protein Vector (Rat) (pPM-C-HA)
20468026 500 ng

FEZ2 Protein Vector (Rat) (pPM-C-HA)

Ask
View Details
Human Monoclonal Siglec-15 Antibody (Medimmune patent anti-Siglec-15) [Janelia Fluor 549]
NBP3-28018JF549 0.1 mL

Human Monoclonal Siglec-15 Antibody (Medimmune patent anti-Siglec-15) [Janelia Fluor 549]

Ask
View Details
UPF3A Human qPCR Primer Pair (NM_023011)
HP214623 200 Reactions

UPF3A Human qPCR Primer Pair (NM_023011)

Ask
View Details